The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Kiselev D.V.

Yaroslavl State Medical University

Lavrukhin V.V.

Yaroslavl Clinical Hospital No 2

The use of a fixed combination of diclofenac and orphenadrine in the treatment of acute pain syndrome in patients with discogenic lumbosacral radiculopathy and lumboischialgia

Authors:

Kiselev D.V., Lavrukhin V.V.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2023;123(3): 122‑129

DOI: 10.17116/jnevro2023123031122

Read: 3839 times

Contact the author
Table of contents

THE USE OF A FIXED COMBINATION OF DICLOFENAC AND ORPHENADRINE IN THE TREATMENT OF ACUTE PAIN SYNDROME IN PATIENTS WITH DISCOGENIC LUMBOSACRAL RADICULOPATHY AND LUMBOISCHIALGIA
THE USE OF A FIXED COMBINATION OF DICLOFENAC AND ORPHENADRINE IN THE TREATMENT OF ACUTE PAIN SYNDROME IN PATIENTS WITH DISCOGENIC LUMBOSACRAL RADICULOPATHY AND LUMBOISCHIALGIA

To cite this article:

Kiselev DV, Lavrukhin VV. The use of a fixed combination of diclofenac and orphenadrine in the treatment of acute pain syndrome in patients with discogenic lumbosacral radiculopathy and lumboischialgia. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;123(3):122‑129. (In Russ.)
https://doi.org/10.17116/jnevro2023123031122

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Recu­rrent pain syndromes in adolescents of different ages. Russian Journal of Pain. 2025;(2):24-31
Biofeedback in complex therapy of pain syndromes. Russian Journal of Pain. 2025;(2):70-75
Comparative analysis of the effe­ctiveness of outpatient reha­bilitation algo­rithms for patients with back pain. Problems of Balneology, Physiotherapy and Exercise Therapy. 2025;(5-2):72-80
Influence of central sensitivity syndrome on symptoms of chro­nic nonspecific low back pain in patients with spinal osteoarthritis. Russian Journal of Pain. 2026;(1):22-30
Leg length discrepancy as a risk factor of lower back pain. Russian Journal of Pain. 2026;(1):82-88
Abstract:

Acute pain syndromes caused by discogenic lumbosacral radiculopathy and lumboischialgia are not uncommon in clinical practice and characterized by a high risk of becoming chronic. The pathogenetic aspects, features of the clinical picture, existing approaches to conservative treatment of these conditions are analyzed in this paper. Data on the efficacy and safety of a fixed combination of diclofenac and orphenadrine (Neodolpasse) use in the treatment of vertebrogenic pain syndromes based on the NEODOLEX study results are presented, and the authors’ own clinical observations are given. Possible reasons for the high efficacy of Neodolpasse in patients with discogenic radiculopathies and nonspecific back and neck pain are discussed.

Keywords:

back pain
lumboischialgia
discogenic lumbosacral radiculopathy
diclofenac
orphenadrine
Neodolpasse

Authors:

Kiselev D.V.

Yaroslavl State Medical University

Lavrukhin V.V.

Yaroslavl Clinical Hospital No 2

Received:

23.01.2023

Accepted:

24.01.2023

Close metadata

References:

  1. Taylor J, Twomey L, Levander B. Contrasts between Cervical and Lumbar Motion Segments. Critical Reviews in Physical and Rehabilitation Medicine. 2000;12(4):28.  https://doi.org/10.1615/critrevphysrehabilmed.v12.i4.40
  2. Breivik H, Collett B, Ventafridda V, et al. Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment. Eur J Pain. 2006;10(4):287-287.  https://doi.org/10.1016/j.ejpain.2005.06.009
  3. Ren XS, Selim AJ, Fincke G, et al. Assessment of Functional Status, Low Back Disability, and Use of Diagnostic Imaging in Patients with Low Back Pain and Radiating Leg Pain. J Clin Epidemiol. 1999;52(11):1063-1071. https://doi.org/10.1016/s0895-4356(99)00094-3
  4. Heliovaara M, Impivaara O, Sievers K, et al. Lumbar disc syndrome in Finland. J Epidem Commun Health. 1987;41(3):251-258.  https://doi.org/10.1136/jech.41.3.251
  5. Bogduk N, McGuirk B. Causes and sources of chronic low back pain. In: Medical Management of Acute and Chronic Low Back pain. An Evidence-Based Approach: Pain Research and Clinical Management. Vol. 13. Amsterdam: Elsevier Science BV№ 2002;115-126. 
  6. Churyukanov MV, Shevtsova GE, Zagorulko OI. A neuropathic component of lumboischialgia: mechanisms of development and treatment approaches. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2017;117(1):90-96. (In Russ.). https://doi.org/10.17116/jnevro20171171190-96
  7. Nikolaeva NS, Danilov AB. Clinical and neurological characteristics of patients with somatic referred back pain at the lumbosacral level. Nevrologija, Nejropsihiatrija, Psihosomatika. 2013;5(4):39-42. (In Russ.). https://doi.org/10.14412/2074-2711-2013-2453
  8. Shirokov VA, Potaturko AV, Terekhov NL, Morozov AA. Fixed combination of orphenadrine and diclofenac in the treatment of acute spondylogenic pain syndromes. Rossijskij Zhurnal Boli. 2021;19(1):19-24. (In Russ.). https://doi.org/10.17116/pain20211901119
  9. Parfenov VA, Yakhno NN, Davydov OS, et al. Discogenic lumbosacral radiculopathy. Recommendations of the Russian Association for the Study of Pain (RSSP). Nevrologija, Nejropsihiatrija, Psihosomatika. 2020;12(4):15-24. (In Russ.). https://doi.org/10.14412/2074-2711-2020-4-15-24
  10. Bogduk N. On the definitions and physiology of back pain, referred pain, and radicular pain. Pain. 2009;147(1-3):17-19.  https://doi.org/10.1016/j.pain.2009.08.020
  11. Feinstein B, Langton JNK, Jameson RM, Schiller F. Experiments on pain reffered from deep somatic tissues. J Bone Joint Surg. 1954;36-A(5):981-997. 
  12. Jinkins JR. The Pathoanatomic Basis of Somatic, Autonomic and Neurogenic Syndromes Originating in the Lumbosacral Spine. Neuroradiol J. 1995;8(1 suppl):35-51.  https://doi.org/10.1177/19714009950080s106
  13. Gillette RG, Kramis RC, Roberts WJ. Characterization of spinal somatosensory neurons having receptive fields in lumbar tissues of cats. Pain. 1993;54(1):85-98.  https://doi.org/10.1016/0304-3959(93)90103-v
  14. Vishnyakova EM, Shirshov YuA, Shirokov VA. Modern clinical and pathogenetic characteristics of main types of back pain. Zabajkal’skij Medicinskij Vestnik. 2020;3:78-84. (In Russ.). https://doi.org/10.52485/19986173_2020_3_78
  15. Nikolaeva NS, Frolov AA, Danilov AB. The effectiveness of drug Katena (gabapentin) for the treatment of chronic somatic reffered back pain. Psihiatrija i Psihofarmakoterapija. 2013;4:60-64. (In Russ).
  16. Merskey H, Bogduk N. Classification of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definition of Pain Terms, edn 2. Seattle: IASP Press; 1994:94-95. 
  17. Donelson R, Aprill C, Medcalf R, Grant W. A Prospective Study of Centralization of Lumbar and Referred Pain. Spine. 1997;22(10):1115-1122. https://doi.org/10.1097/00007632-199705150-00011
  18. Kobayashi S, Baba H, Uchida K, et al. Effect of Mechanical Compression on the Lumbar Nerve Root: Localization and Changes of Intraradicular Inflammatory Cytokines, Nitric Oxide, and Cyclooxygenase. Spine. 2005;30(15):1699-1705. https://doi.org/10.1097/01.brs.0000171910.97937.0e
  19. Videman T, Nurminen M. The Occurrence of Anular Tears and Their Relation to Lifetime Back Pain History: A Cadaveric Study Using Barium Sulfate Discography. Spine. 2004;29(23):2668-2676. https://doi.org/10.1097/01.brs.0000146461.27105.2b
  20. Sun Z, Zhang M, Zhao XH, et al. Immune cascades in human intervertebral disc: the pros and cons. Int J Clin Exp Pathol. 2013;6(6):1009-1014.
  21. Stafford M, Peng P, Hill D. Sciatica: a review of history, epidemiology, pathogenesis, and the role of epidural steroid injection in management. Br J Anaest. 2007;99(4):461-473.  https://doi.org/10.1093/bja/aem238
  22. Weiler C, Nerlich A, Bachmeier B, Boos N. Expression and distribution of tumor necrosis factor alpha in human lumbar intervertebral discs: a study in surgical specimen and autopsy controls. Spine. 2005;30(1):44-53.  https://doi.org/10.1097/01.brs.0000149186.63457.20
  23. Omarker K, Myers RR. Pathogenesis of sciatic pain: role of herniated nucleus pulposus and deformation of spinal nerve root and dorsal root ganglion. Pain. 1998;78(2):99-105.  https://doi.org/10.1016/s0304-3959(98)00119-5
  24. Di Martino A, Merlini L, Faldini C. Autoimmunity in intervertebral disc herniation: from bench to bedside. Expert Opin Ther Targets. 2013;17:1461-1470. https://doi.org/10.1517/14728222.2013.834330
  25. Park JY, Kuh SU, Park HS, et al. Comparative expression of matrix associated genes and inflammatory cytokines-associated genes according to disc degeneration: analysis of living human nucleus pulposus. J Spinal Disord Tech. 2011;24:352-357.  https://doi.org/10.1097/bsd.0b013e3181fee4df
  26. Yang H, Liu H, Li Z, et al. Low back pain associated with lumbar disc herniation: role of moderately degenerative disc and annulus fibrous tears. Int J Clin Exp Med. 2015;8(2):1634-1644.
  27. Freemont AJ, Peacock TE, Goupille P, et al. Nerve ingrowth into diseased intervertebral disc in chronic back pain. Lancet. 1997;350:178-181.  https://doi.org/10.1016/s0140-6736(97)02135-1
  28. Chiu CC, Chuang TY, Chang KH, et al. The probability of spontaneous regression of lumbar herniated disc: a systematic review. Clin Rehabil. 2015;29(2):184-195.  https://doi.org/10.1177/0269215514540919
  29. Macki M, Hernandez-Hermann M, Bydon M, et al. Spontaneous regression of sequestrated lumbar disc herniations: Literature review. Clin Neurol Neurosurg. 2014;120:136-141.  https://doi.org/10.1016/j.clineuro.2014.02.013
  30. Schistad EI, Espeland A, Pedersen LM, et al. Association between baseline IL-6 and 1-year recovery in lumbar radicular pain. Eur J Pain. 2014;18(10):1394-1401. https://doi.org/10.1002/j.1532-2149.2014.502.x
  31. Amelin AV, Akhmadeeva LR, Achkasov EV, et al. Diagnosis and treatment of musculoskeletal (non-specific) lower back pain. Clinical guidelines. Moscow: Russian Association for the Study of Pain, 2021. (In Russ).
  32. Instruction for the drug for medical use Neodolpasse. (In Russ.). https://grls.rosminzdrav.ru
  33. Gan TJ. Diclofenac: an update on its mechanism of action and safety profile. Curr Med Res Opin. 2010;26(7):1715-1731. https://doi.org/10.1185/03007995.2010.486301
  34. Amelin AV. A fixed combination of orphenadrine and diclofenac, as possibilities of multimodal therapy of pain and muscle spasm. Rossijskij zhurnal boli. 2019;17(4):50-53. (In Russ.). https://doi.org/10.25731/RASP.2019.04.41
  35. Atzeni F, Masala IF, Sarzi-Puttini P. A Review of Chronic Musculoskeletal Pain: Central and Peripheral Effects of Diclofenac. Pain Ther. 2018;7(2):163-177.  https://doi.org/10.1007/s40122-018-0100-2
  36. Chou R, Peterson K, Helfand M. Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review. J Pain Symptom Manage. 2004;28(2):140-175.  https://doi.org/10.1016/j.jpainsymman.2004.05.002
  37. Hunskaar S, Donnell D. Clinical and pharmacological review of the efficacy of orphenadrine and its combination with paracetamol in painful conditions. J Int Med Res. 1991;19(2):71-87.  https://doi.org/10.1177/030006059101900201
  38. Schaffler K, Reitmeir P, Gschanes A, Eggenreich U. Comparison of the analgesic effects of a fixed-dose combination of orphenadrine and diclofenac (Neodolpasse) with its single active ingredients diclofenac and orphenadrine: A placebo-controlled study using laser-induced somatosensory-evoked potentials from capsaicin-induced hyperalgesic human skin. Drugs in R & D. 2005;6(4):189-199.  https://doi.org/10.2165/00126839-200506040-00001
  39. Borsodi M, Nagy E, Darvas K. Diclofenac/orphenadrin kombinált analgetikum a posztoperatív fájdalomcsillapításban. Diclofenac/orphenadrine as a combined analgetic in post-operative relief of pain]. Orv Hetil. 2008;149(39):1847-1852. https://doi.org/10.1556/OH.2008.28419
  40. Eremenko AA, Sorokina LS, Ryabova DV, Urbanov AV. Analgesic and opioid-sparing effects of a fixed combination of diclofenac and orphenadrine in the early postoperative period in cardiac surgery patients. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2022;122(10):109-115. (In Russ.). https://doi.org/10.17116/jnevro2022122101109
  41. Málek J, Nedӗlová I, Lopourová M, et al. Diklofenak 75 mg s orfenadinem 30 mg (NEODOLPASSE) versus placebo a piroxikam v pooperacní analgezii u artroskopií [Diclofenac 75mg. and 30 mg. orfenadine (Neodolpasse) versus placebo and piroxicam in postoperative analgesia after arthroscopy. Acta Chir Orthop Traumatol Cech. 2004;71(2):80-83. (In Czech.).
  42. Aglas F, Fruhwald FM, Chlud K. Ergebnisse einer Anwendungsbeobachtung mit Diclofenac/Orphenadrin-Infusionen bei Patienten mit muskuloskelettalen Krankheiten und Funktionsstörungen. [Results of efficacy study with diclofenac/orphenadrine infusions in patients with musculoskeletal diseases and functional disorders]. Acta Med Austriaca. 1998;25(3):86-90. 
  43. Uitz E, Aglas F, Wurm A, Rainer F. Diclofenac/Orphenadrin-Infusionstherapie bei Patienten mit aktivierten Arthrosen. [Diclofenac/orphenadrine infusion therapy in patients with active arthrosis]. Wien Med Wochenschr. 1998;148(7):179-182. 
  44. Amelin AV, Balyazin VA, Davydov OS, et al. Russian multicenter study of fixed combination of diclofenac and orphenadrine its efficacy and tolerance of in acute non-specific pain and radiculopathy relief. Rossijskij Zhurnal Boli. 2022;20(1):33-41. (In Russ.). https://doi.org/10.17116/pain20222001133
  45. Nasonov EL, Yakhno NN, Karateev AE, et al. General principles of treatment for musculoskeletal pain: Interdisciplinary consensus. Nauchno-Prakticheskaya Revmatologiya. 2016;54(3):247-265. (In Russ.). https://doi.org/10.14412/1995-4484-2016-247-265
  46. Corp N, Mansell G, Stynes S, et al. Evidence-based treatment recommendations for neck and low back pain across Europe: A systematic review of guidelines. Eur J Pain. 2021;25(2):275-295.  https://doi.org/10.1002/ejp.1679
  47. Cohen SP. Epidemiology, diagnosis, and treatment of neck pain. Mayo Clin Proc. 2015;90(2):284-299.  https://doi.org/10.1016/j.mayocp.2014.09.008
  48. Chou R, Deyo R, Friedly J, et al. Systemic Pharmacologic Therapies for Low Back Pain: A Systematic Review for an American College of Physicians Clinical Practice Guideline. Ann Intern Med. 2017;166(7):480-492.  https://doi.org/10.7326/M16-2458
  49. Van der Gaag WH, Roelofs PD, Enthoven WT, et al. Non-steroidal anti-inflammatory drugs for acute low back pain. Cochrane Database Syst Rev. 2020;4(4):CD013581. https://doi.org/10.1002/14651858.CD013581
  50. Roelofs PD, Deyo RA, Koes BW, et al. Non-steroidal anti-inflammatory drugs for low back pain. Cochrane Database Syst Rev. 2008;(1):CD000396. https://doi.org/10.1002/14651858.CD000396.pub3
  51. Machado GC, Maher CG, Ferreira PH, et al. Non-steroidal anti-inflammatory drugs for spinal pain: a systematic review and meta-analysis. Ann Rheum Dis. 2017;76(7):1269-1278. https://doi.org/10.1136/annrheumdis-2016-210597
  52. Karateev AE, Nasonov EL, Ivashkin VT, et al. Rational use of nonsteroidal anti-inflammatory drugs. Clinical guidelines. Nauchno-Prakticheskaja Revmatologija. 2018;56:1-29. (In Russ.). https://doi.org/10.14412/1995-4484-2018-1-29
  53. van Tulder MW, Touray T, Furlan AD, et al. Muscle relaxants for non-specific low back pain. Cochrane Database Syst Rev. 2003;2003(2):CD004252. https://doi.org/10.1002/14651858.CD004252
  54. Abdel Shaheed C, Maher CG, Williams KA, et al. Efficacy and tolerability of muscle relaxants for low back pain: Systematic review and meta-analysis. Eur J Pain. 2017;21(2):228-237.  https://doi.org/10.1002/ejp.907
  55. Chang WJ. Muscle Relaxants for Acute and Chronic Pain. Phys Med Rehabil Clin N Am. 2020;31(2):245-254.  https://doi.org/10.1016/j.pmr.2020.01.005
  56. Csiba L, Zhussupova AS, Likhachev SA, et al. A systematic review of using myorelaxants in treatment of low back pain. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2018;118(12):100-113. (In Russ.). https://doi.org/10.17116/jnevro2018118121100
  57. Barinov AN. Segmental mechanisms of muscle spasm, spasticity, and pain chronification. Vrach. 2012;5:17-23. (In Russ.).
  58. Smith H, Pappagallo M, Stahl S. Essential Pain Pharmacology: The Prescriber’s Guide. Cambridge: Cambridge University Press; 2012. https://doi.org/10.1017/CBO9781139194464
  59. Kornhuber J, Parsons CG, Hartmann S, et al. Orphenadrine is an uncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist: binding and patch clamp studies. J Neural Transm Gen Sect. 1995;102(3):237-246.  https://doi.org/10.1007/BF01281158
  60. Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. Pain. 2011;152(3 suppl):2-15.  https://doi.org/10.1016/j.pain.2010.09.030
  61. Biella GE, Groppetti A, Novelli A, et al. Neuronal sensitization and its behavioral correlates in a rat model of neuropathy are prevented by a cyclic analog of orphenadrine. J Neurotrauma. 2003;20(6):593-601.  https://doi.org/10.1089/089771503767168519
  62. Schaffler K, Reitmeir P. Analgesic effects of low-dose intravenous orphenadrine in the state of capsaicin hyperalgesia. A randomised, placebo-controlled, double-blind cross-over study using laser somatosensory evoked potentials obtained from capsaicin-irritated skin in healthy volunteers. Arzneimittelforschung. 2004;54(10):673-679.  https://doi.org/10.1055/s-0031-1297020
  63. Schaffler K, Reitmeir P, Gschanes A, Eggenreich U. Comparison of the analgesic effects of a fixed-dose combination of orphenadrine and diclofenac (Neodolpasse) with its single active ingredients diclofenac and orphenadrine: a placebo-controlled study using laser-induced somatosensory-evoked potentials from capsaicin-induced hyperalgesic human skin. Drugs RD. 2005;6(4):189-199.  https://doi.org/10.2165/00126839-200506040-00001
  64. Low back pain and sciatica in over 16s: assessment and management. London: National Institute for Health and Care Excellence (NICE); 2020 Dec 11. 
  65. Stochkendahl MJ, Kjaer P, Hartvigsen J, et al. National Clinical Guidelines for non-surgical treatment of patients with recent onset low back pain or lumbar radiculopathy. Eur Spine J. 2018;27(1):60-75.  https://doi.org/10.1007/s00586-017-5099-2
  66. Cashin AG, Folly T, Bagg MK, et al. Efficacy, acceptability, and safety of muscle relaxants for adults with non-specific low back pain: systematic review and meta-analysis. BMJ. 2021;374:n1446. https://doi.org/10.1136/bmj.n1446
  67. Rasmussen-Barr E, Held U, Grooten WJ, et al. Non-steroidal anti-inflammatory drugs for sciatica. Cochrane Database Syst Rev. 2016;10(10):CD012382. https://doi.org/10.1002/14651858.CD012382
  68. Tramer MR, Williams JE, Carroll D, et al. Comparing analgesic efficacy of non-steroidal anti-inflammatory drugs given by different routes in acute and chronic pain: A qualitative systematic review. Acta Anaesthesiol Scand. 1998;42(1):71-79.  https://doi.org/10.1111/j.1399-6576.1998.tb05083.x
  69. Desaphy JF, Dipalma A, De Bellis M, et al. Involvement of voltage-gated sodium channels blockade in the analgesic effects of orphenadrine. Pain. 2009;142(3):225-235.  https://doi.org/10.1016/j.pain.2009.01.010
  70. Rossettini G, Carlino E, Testa M. Clinical relevance of contextual factors as triggers of placebo and nocebo effects in musculoskeletal pain. BMC Musculoskelet Disord. 2018 Jan 22;19(1):27.  https://doi.org/10.1186/s12891-018-1943-8
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.